MOOLEC SCIENCE (MLEC)
(Delayed Data from NSDQ)
$0.87 USD
0.00 (0.01%)
Updated Aug 30, 2024 02:53 PM ET
After-Market: $0.87 0.00 (-0.01%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Moolec Science SA falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | |
---|---|---|---|---|---|
Sales | NA | 1 | 0 | 0 | 0 |
Cost Of Goods | NA | 1 | 0 | 0 | 0 |
Gross Profit | NA | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 7 | 1 | 2 | 0 |
Income After Depreciation & Amortization | 0 | -7 | -1 | -2 | 0 |
Non-Operating Income | NA | -45 | 1 | 2 | 0 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | NA | -52 | 0 | 0 | 0 |
Income Taxes | NA | 0 | 0 | 0 | 0 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -52 | 0 | 0 | 0 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -52 | 0 | 0 | 0 |
Depreciation Footnote | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -7 | -1 | -2 | 0 |
Depreciation & Amortization (Cash Flow) | NA | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | 0 | -7 | -1 | -2 | 0 |
Earnings Per Share Data | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Average Shares | NA | 34.47 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | -1.50 | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | -1.50 | NA | -0.01 | NA |
Fiscal Year end for Moolec Science SA falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 2.11 | 0.25 | 1.74 | 0.91 |
Cost Of Goods | NA | 2.02 | 0.02 | 1.52 | 1.05 |
Gross Profit | NA | 0.09 | 0.23 | 0.22 | -0.14 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2.14 | 2.03 | 2.49 | 4.83 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -2.05 | -1.80 | -2.27 | -4.97 |
Non-Operating Income | NA | 1.13 | -0.12 | 0.55 | 2.03 |
Interest Expense | NA | 0.36 | 0.10 | 0.09 | 0.16 |
Pretax Income | NA | -1.28 | -2.02 | -1.81 | -3.11 |
Income Taxes | NA | 0.13 | -0.24 | -0.22 | -0.24 |
Minority Interest | NA | NA | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | NA | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | NA | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -1.40 | -1.78 | -1.59 | -2.87 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.40 | -1.78 | -1.59 | -2.87 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 35.05 | 35.66 | 39.78 | NA |
Diluted EPS Before Non-Recurring Items | NA | -0.04 | -0.05 | -0.04 | NA |
Diluted Net EPS (GAAP) | NA | -0.04 | -0.05 | -0.04 | NA |